Myeloma: Pathology, Diagnosis, and Treatment

Myeloma: Pathology, Diagnosis, and Treatment

by Stephen A. Schey
     
 

View All Available Formats & Editions

Myeloma is the second-most common hematologic cancer, accounting for approximately 1 percent of all cancers and 2 percent of all deaths from cancer. In recent years there have been major and significant advances in the diagnosis, imaging, molecular pathogenesis, and therapy of myeloma. This book describes these advances in a single, practical volume, placing them

Overview

Myeloma is the second-most common hematologic cancer, accounting for approximately 1 percent of all cancers and 2 percent of all deaths from cancer. In recent years there have been major and significant advances in the diagnosis, imaging, molecular pathogenesis, and therapy of myeloma. This book describes these advances in a single, practical volume, placing them in the context of daily clinical practice. Different myeloma subtypes are discussed in individual chapters, integrating etiology, pathogenesis, molecular pathology, histology, and therapy in a single place for each condition. The book begins by discussing epidemiology, imaging techniques, pathogenesis, and other general considerations. Conditions covered in detail include multiple myeloma, POEMS syndrome, Castleman's syndrome, Waldenstrom's macroglobulinemia, amyloidosis and MGUS. Featuring color illustrations, and written and edited by leading authorities in the field, Myeloma provides readers with the information they need to diagnose and manage these complex disorders.

Editorial Reviews

Doody's Review Service
Reviewer: Firoozeh Sahebi, M.D.(City of Hope)
Description: This book addresses different aspects of the debilitating disease of myeloma, including epidemiology, biology, pathogenesis, diagnosis, and treatment, and reviews other plasma cell dyscrasia such as POEMS syndrome, Castleman disease, amyloidosis, and Waldenstrom macroglobulinemia.
Purpose: The purpose is to provide a deeper understanding of the disease biology, from cell cycle regulation, signaling pathways, genetic and epigenetic changes to the role of bone marrow microenvironment, with six chapters dedicated to these topics. The book provides a collective understanding of the disease biology and descriptions of carefully designed clinical studies. It reviews the recent advances in the diagnosis and treatment of the disease and provides an important source of information for clinicians and scientists in the field.
Audience: The book is written for healthcare professionals, including physicians, nurse practitioners, scientists, and researchers. The authors are the expert authorities in the field.
Features: The strength of the book is its clear presentation of the existing knowledge of the biology of the disease and diagnosis. The short, well-written chapters include figures, tables, graphs, and imaging studies useful for conceptualizing the information. Treatment strategies are summarized based on pivotal phase II and randomized phase III studies with relevant references. However, two important areas of ongoing research in the treatment of the disease are missing. One is the exciting and accumulating data on the role of minimal residual disease (MRD). Although this is mentioned in the first chapter under diagnosis, its influence in predicting outcome and directing therapeutic decisions in the near future requires an in-depth discussion in the treatment chapter. The second topic is the active research into using new targeted agents and radiation technology (i.e. IMRT) as conditioning regimens in the field of transplantation. These areas of research among many others are important in advancing the field.
Assessment: This is a well-written and well-structured book focused on disease biology, which is the backbone of present and future treatment strategies. It is an important source of information for both clinicians and researchers.

Product Details

ISBN-13:
9781107010574
Publisher:
Cambridge University Press
Publication date:
11/30/2013
Pages:
305
Product dimensions:
7.70(w) x 9.70(h) x 0.70(d)

Related Subjects

Meet the Author

Stephen A. Schey is Professor of Plasma Cell Dyscrasias, King's College London, and a Consultant Haematologist at King's College Hospital NHS Foundation Trust, London.

Kwee L. Yong is Professor of Clinical Haematology, University College London, and a Consultant Haematologist at University College London Hospitals, London.

Robert Marcus is a Consultant Haematologist at King's College Hospital NHS Foundation Trust, London.

Kenneth C. Anderson is Kraft Family Professor of Medicine, Harvard Medical School, and Medical Director, Kraft Family Blood Donor Center, Dana-Faber Cancer Institute, Boston.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >